[HTML][HTML] FDG PET-CT for solitary pulmonary nodule and lung cancer: literature review
D Groheux, G Quere, E Blanc, C Lemarignier… - Diagnostic and …, 2016 - Elsevier
The investigation of solitary pulmonary nodule (SPN) and non-small cell lung cancer
(NSCLC) has rapidly become one of the main indications for 18 F-fluorodeoxyglucose (FDG) …
(NSCLC) has rapidly become one of the main indications for 18 F-fluorodeoxyglucose (FDG) …
Biology of hypoxia
PN Span, J Bussink - Seminars in nuclear medicine, 2015 - Elsevier
There is an important and strong, but complex influence of the tumor microenvironment on
tumor cells׳ phenotype, aggressiveness, and treatment sensitivity. One of the most frequent …
tumor cells׳ phenotype, aggressiveness, and treatment sensitivity. One of the most frequent …
[HTML][HTML] Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
FHP van Velden, GM Kramer, V Frings… - Molecular imaging and …, 2016 - Springer
Purpose To assess (1) the repeatability and (2) the impact of reconstruction methods and
delineation on the repeatability of 105 radiomic features in non-small-cell lung cancer …
delineation on the repeatability of 105 radiomic features in non-small-cell lung cancer …
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
S Löck, R Perrin, A Seidlitz, A Bandurska-Luque… - Radiotherapy and …, 2017 - Elsevier
Background Hypoxia is a well recognised parameter of tumour resistance to radiotherapy, a
number of anticancer drugs and potentially immunotherapy. In a previously published …
number of anticancer drugs and potentially immunotherapy. In a previously published …
[HTML][HTML] Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
SC Vaz, JA Adam, RCD Bolton, P Vera… - European journal of …, 2022 - Springer
Abstract Purpose 2-[18 F] FDG PET/CT is of utmost importance for radiation treatment (RT)
planning and response monitoring in lung cancer patients, in both non-small and small cell …
planning and response monitoring in lung cancer patients, in both non-small and small cell …
The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer
S Sheikhbahaei, E Mena… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …
[HTML][HTML] PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions
C Eze, NS Schmidt-Hegemann, LM Sawicki… - European journal of …, 2021 - Springer
Purpose The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment
of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative …
of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative …
[HTML][HTML] A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT
Background 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed
tomography (CT) has been an essential modality in oncology. We propose a semi …
tomography (CT) has been an essential modality in oncology. We propose a semi …
PET in the management of locally advanced and metastatic NSCLC
W Grootjans, LF de Geus-Oei, EGC Troost… - Nature reviews Clinical …, 2015 - nature.com
Despite considerable improvements in the treatment options for advanced-stage non-small-
cell lung cancer (NSCLC), disease-specific survival remains poor. With the aim of improving …
cell lung cancer (NSCLC), disease-specific survival remains poor. With the aim of improving …
Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A …
M Cremonesi, L Gilardi, ME Ferrari, G Piperno… - European journal of …, 2017 - Springer
Abstract Background Non-Small Cell Lung Cancer (NSCLC) is characterized by
aggressiveness and includes the majority of thorax malignancies. The possibility of early …
aggressiveness and includes the majority of thorax malignancies. The possibility of early …